🔎 Trials Near Me

Home › Dermatomyositis › Texas › Houston

Pag-aaral pangklinika para sa Dermatomyositis sa Houston, TX

Isang pag-aaral para sa Dermatomyositis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Nagre-recruitPhase 2/3
  • Houston Methodist Hospital - Accepting Adult Patients, Houston
  • University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06154252

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1
  • UT MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Nagre-recruitPhase 3
  • Nerve & Muscle Center of Texas, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05895786

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

Nagre-recruitPhase 3
  • Nerve & Muscle Center of Texas, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06698796

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Nagre-recruitPhase 1
  • Nerve and Muscle Center of Texas, Houston
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06371417

Pag-aaral para sa Dermatomyositis sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.